SCM
EXAS

Shelton Capital Management’s Exact Sciences EXAS Stock Holding History

Shelton Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5,467
Closed -$494K – 845
2019
Q3 		$494K Buy
+5,467
New +$623K 0.03% 349
2018
Q2 		– Sell
-8,800
Closed -$355K – 868
2018
Q1 		$355K Hold
8,800
– – 0.02% 481
2017
Q4 		$462K Hold
8,800
– – 0.03% 407
2017
Q3 		$415K Hold
8,800
– – 0.03% 431
2017
Q2 		$311K Hold
8,800
– – 0.02% 548
2017
Q1 		$208K Buy
+8,800
New +$174K 0.01% 801
2015
Q3 		– Sell
-7,000
Closed -$208K – 752
2015
Q2 		$208K Buy
+7,000
New +$176K 0.02% 733

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Shelton Capital Management's EXAS Position: Q4 2019 in Review

Shelton Capital Management sold out of Exact Sciences (EXAS) in Q4 2019, closing a stake of 5,467 shares — an estimated $494K sold.

Shelton Capital Management first reported a position in EXAS in Q2 2015 and held it in 7 quarters. The position peaked at $494K in Q3 2019. 527 funds tracked by Wall St. Rank hold EXAS as of Q4 2019.

  • Shelton Capital Management reported no remaining Exact Sciences position as of Q4 2019 after selling out during the quarter.
  • Shelton Capital Management sold 5,467 Exact Sciences shares in Q4 2019, an estimated $494K.
  • Shelton Capital Management first reported a position in Exact Sciences in Q2 2015 and held it in 7 quarters.
  • Shelton Capital Management's Exact Sciences position peaked at $494K in Q3 2019.
  • 527 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2019.

Based on Shelton Capital Management's 13F filing for Q4 2019, filed 11 Feb 2020.